REVVITY, INC. (RVTY) Form 10-Q Quarterly Reports
REVVITY, INC. (RVTY) is a publicly traded company on the NYSE, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RVTY
CIK: 31791
Exchange: NYSE
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/29
State: MA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Angelo Belonio
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0000080255-26-000608 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412237 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001959173-26-007172 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 | 0001193125-26-399376 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001959173-26-007045 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | 4 | 0001193125-26-395510 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001959173-26-006999 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-08 | — | SCHEDULE 13G/A Filing | 0001897612-26-000628 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-25 | 4 | 0001193125-26-365114 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 | 0001193125-26-355406 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001193125-26-354025 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001897612-26-000590 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000080255-26-000540 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-07-05 | 10-Q | 0000031791-26-000027 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0000031791-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-07-20 | 4 | 0001193125-26-312389 | View SEC Doc Filr Page |
| 144 | 2026-07-20 | — | 144 Filing | 0001959173-26-005275 | View SEC Doc Filr Page |
| 25-NSE | 2026-07-20 | — | 25-NSE Filing | 0000876661-26-000629 | View SEC Doc Filr Page |
| 11-K | 2026-06-23 | 2025-12-31 | 11-K | 0001193125-26-279766 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274133 | View SEC Doc Filr Page |
| SD | 2026-06-01 | — | SD | 0001193125-26-249770 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000080255-26-000397 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-04-05 | 10-Q | 0000031791-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-216736 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 | 0001193125-26-216734 | View SEC Doc Filr Page |